650-263-7636   contact@endothelix.com             YouTube                                                                       

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

Endothelial Dysfunction in COVID-19:
Lessons Learned from Coronaviruses
Abstract
To review current literature on endothelial dysfunction with previous coronaviruses, and present available data on the role of endothelial dysfunction in coronavirus disease-2019 (COVID-19) infection in terms of pathophysiology and clinical phenotype RECENT FINDINGS: Recent evidence suggests that signs and symptoms of severe COVID-19 infection resemble the clinical phenotype of endothelial dysfunction, implicating mutual pathophysiological pathways. Dysfunction of endothelial cells is believed to mediate a variety of viral infections, including those caused by previous coronaviruses. Experience from previous coronaviruses has triggered hypotheses on the role of endothelial dysfunction in the pathophysiology of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which are currently being tested in preclinical and clinical studies. Endothelial dysfunction is the common denominator of multiple clinical aspects of severe COVID-19 infection that have been problematic for treating physicians. Given the global impact of this pandemic, better understanding of the pathophysiology could significantly affect management of patients.
Keywords: COVID-19; Complement; Endothelial dysfunction; SARS-COV-2; Thrombosis; Thrombotic microangiopathy.

LATEST SCIENTIFIC UPDATES